Related Experiment Video
Updated: Jul 3, 2026

08:27
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
Restoring cortical disinhibition improves Huntington's disease phenotypes
Sonja Blumenstock1,2,3,4, David Arakelyan5,6, Nicholas Del Grosso7
1Department of Neurobiology, Center for Neural Circuits and Behavior, University of California San Diego, La Jolla, CA, USA. sblumenstock@ucsd.edu.
Nature
|July 1, 2026
Summary
Huntington's disease (HD) motor deficits involve specific cortical neuron issues. Stimulating vasoactive intestinal peptide (VIP) inhibitory neurons improved motor function in HD mice, suggesting a therapeutic target.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder with poorly understood behavioral symptoms.
- Cortical dysfunction is implicated in HD, but specific neuronal subtypes' roles are unclear.
Purpose of the Study:
- Investigate cortical neuronal subtype activity in HD progression.
- Identify potential therapeutic targets for HD.
Main Methods:
- Longitudinal in vivo two-photon calcium imaging in R6/2 HD mouse model.
- Examined activity of inhibitory neuron (IN) subtypes and corticostriatal (CStr) neurons.
- Used optogenetics to activate VIP-INs and assess behavioral rescue.
Main Results:
- HD motor deficits correlated with subtype-specific neuronal hypoactivity, notably in VIP-INs and CStr neurons.
- Optogenetic VIP-IN activation normalized neuronal activity and ameliorated motor deficits in R6/2 mice.
- Behavioral improvements persisted post-stimulation, indicating lasting therapeutic effects.
Conclusions:
- Cortical inhibitory neurons, particularly VIP-INs, are critically involved in HD pathogenesis.
- VIP-INs represent a promising therapeutic target for Huntington's disease.

